The DOJ And FTC Issue Their Second Report On The Interface Of IP And Antitrust Law
Client Alert | 2 min read | 04.18.07
Yesterday, the U.S. Department of Justice (“DOJ”) and the Federal Trade Commission (“FTC”) issued their long-awaited second report on the interface between Antitrust and Intellectual Property laws. In 2002, the agencies held hearings on this issue, receiving testimony from more than 300 panelists and more than 100 written comments. In October, 2003, the FTC issued the first report entitled “To Promote Innovation: The Proper Balance Of Competition And Patent Law And Policy.” See http://www.ftc.gov/os/2003/10/innovationrpt.pdf. The FTC Report focused on recommendations for improving the performance of the patent system. It has since been cited by Justices of the U.S. Supreme Court with respect to the proliferation of so-called “patent trolls,” and for the question of whether the patent system as currently administered strikes the proper balance between IP and Antitrust law.
The agencies’ most recent report, entitled “Antitrust Enforcement and Intellectual Property Rights: Promoting Innovation and Competition,” contains 123 pages of text and many attachments. See http://www.usdoj.gov/atr/public/hearings/ip/222655.htm. Its focus is the antitrust side of the IP-antitrust interface, noting that in the vast majority of cases, the agencies will evaluate IP issues “using the flexible rule of reason.” In summary, the report concludes that:
- There is generally no antitrust liability for unilateral, unconditional refusals to license patents. However, conditional refusals to license patents which may cause competitive harm are subject to antitrust scrutiny.
- Joint negotiation of licensing terms by standard-setting organization (SSO) participants prior to setting a standard can be procompetitive and are likely to be subject to a rule of reason. The Report also recounts the three cases brought by the FTC challenging an SSO participant’s failure to disclose relevant IP.
- Combining complementary patents into a pool is generally procompetitive. However, the agencies have challenged certain pools incorporating substitute technologies because they may tend to raise royalty rates.
- The agencies will continue to apply a rule of reason analysis to assess intellectual property licensing agreements, including non-assertion clauses, grantbacks, and reach-through royalty agreements.
- The agencies reaffirmed their use of the Antitrust-IP Guidelines (see http://www.usdoj.gov/atr/public/guidelines/0558.htm) to analyze intellectual property tying and bundling issues. They reported on a number of concerns expressed by business participants during the hearings, but reiterated their view that such issues should be evaluated based on whether there is market power in the tying product and whether there are strong efficiency justifications to support the bundle.
In evaluating the competitive effects of practices that extend beyond a patent’s expiration, the agencies will begin by determining whether the patent in question confers market power. If so, these practices will generally be evaluated under a rule of reason analysis, unless the agencies believe the practice is merely a sham to cover naked price fixing or market allocations.
Contacts
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development


